EMA/PE/0000245146 - paediatric investigation plan

Insulin lispro (BC222)
PIPHuman

Slovak is available via eTranslation, the European Commission's machine translation service.

Translate to Slovak | Important information about machine translation

Key facts

Active substance
Insulin lispro (BC222)
Therapeutic area
Endocrine disorders
Decision number
EMA/PE/0000245146
PIP number
EMA/PE/0000245146
Pharmaceutical form(s)
  • Solution for injection
  • Solution for infusion
Condition(s) / indication(s)
  • Treatment of type 1 diabetes mellitus
  • Treatment of type 2 diabetes mellitus
Route(s) of administration
Subcutaneous use
Contact for public enquiries

email: v.janet@adocia.com
tel: +33 472610610

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date
Compliance check done
Nie

Decision

Share this page